Literature DB >> 19560023

Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors.

Debra A Gervais1, S Nahum Goldberg, Daniel B Brown, Michael C Soulen, Steven F Millward, Dheeraj K Rajan.   

Abstract

Focal tumor ablation--whether applied percutanously, laparoscopically, or by means of open surgery--is an effective therapy for selected liver tumors. The choice of liver ablation as well as the choice between percutaneous and surgical approaches is dependent on tumor factors, patient factors, and other viable treatment options. Currently, the largest cumulative reported experience is with radiofrequency (RF) ablation of hepatocellular carcinoma and colorectal metastases. This document is a position statement of the Interventional Oncology Task Force and the Standards Division of the Society of Interventional Radiology regarding the use of percutaneous RF ablation for the treatment of liver tumors.

Entities:  

Year:  2009        PMID: 19560023     DOI: 10.1016/j.jvir.2009.04.029

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  27 in total

1.  Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004).

Authors:  T Ruers; C Punt; F Van Coevorden; J P E N Pierie; I Borel-Rinkes; J A Ledermann; G Poston; W Bechstein; M A Lentz; M Mauer; E Van Cutsem; M P Lutz; B Nordlinger
Journal:  Ann Oncol       Date:  2012-03-19       Impact factor: 32.976

Review 2.  [Interventional procedures for hepatic metastases].

Authors:  T Helmberger
Journal:  Chirurg       Date:  2010-06       Impact factor: 0.955

Review 3.  Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy.

Authors:  Yasunori Minami; Naoshi Nishida; Masatoshi Kudo
Journal:  Eur Radiol       Date:  2019-04-08       Impact factor: 5.315

4.  Long-term survival following radiofrequency ablation of colorectal liver metastases: A retrospective study.

Authors:  Simeon Niyi Babawale; Thomas Mandøe Jensen; Jens Brøndum Frøkjær
Journal:  World J Gastrointest Surg       Date:  2015-03-27

5.  Multiphysics modeling toward enhanced guidance in hepatic microwave ablation: a preliminary framework.

Authors:  Jarrod A Collins; Jon S Heiselman; Logan W Clements; Daniel B Brown; Michael I Miga
Journal:  J Med Imaging (Bellingham)       Date:  2019-05-20

Review 6.  RFA plus lyso-thermosensitive liposomal doxorubicin: in search of the optimal approach to cure intermediate-size hepatocellular carcinoma.

Authors:  Riccardo Lencioni; Dania Cioni
Journal:  Hepat Oncol       Date:  2016-06-10

7.  Percutaneous intraductal radiofrequency ablation combined with biliary stent placement for treatment of malignant biliary obstruction.

Authors:  Tianzhu Yu; Wei Zhang; Changyu Li; Chenggang Wang; Gaoquan Gong; Liangwen Wang; Guoping Li; Yi Chen; Xiaolin Wang
Journal:  Abdom Radiol (NY)       Date:  2020-11

8.  Ultrasound-guided intratumoral delivery of doxorubicin from in situ forming implants in a hepatocellular carcinoma model.

Authors:  Luis Solorio; Hanping Wu; Christopher Hernandez; Mihika Gangolli; Agata A Exner
Journal:  Ther Deliv       Date:  2016

Review 9.  Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective.

Authors:  Riccardo Lencioni; Thierry de Baere; Robert C Martin; Charles W Nutting; Govindarajan Narayanan
Journal:  Liver Cancer       Date:  2015-10-21       Impact factor: 11.740

Review 10.  The state of irreversible electroporation in interventional oncology.

Authors:  Mikhail Silk; David Tahour; Govindarajan Srimathveeravalli; Stephen B Solomon; Raymond H Thornton
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.